Publisher's Synopsis
Recombinant human erythropoietin (rHuEPO) has proved to be a major breakthrough in the treatment of renal anaemia. The research which has recently been carried out in this important field was demonstrated at the symposium of the International Society of Blood Purification, held in Montpellier in September 1989. This resulting proceedings issue details the latest advances in the understanding and treatment of renal anaemia. Combining practical information with state-of-the-art expertise, the publication should be of interest to both basic and clinical investigators in the fields of nephrology, haematology, biochemistry and pharmacology.
